Original document(12 pages) Authorized document(12 pages) 中文版
    The medicine for preventing and treating osteoporosis is prepared with the natural plants drynaria rhizome, desert cistanche, malaytea scurfpea fruit, epimedium, American ginseng, etc. and through drying, crushing, decoction and solvent extraction, mixing, disinfection and other steps of prepare medicine powder or table. The said preparation process can maintain the biological activity of the medicine components, and the medicine can raise the sexual hormone level of the body, stimulate the osteoplast to secret collagenase, release grorth factor and cell factor, raise the activity of the osteoplast to promote the production of bone matrix, speed the bone formation process, inhibit the dynamic balance of osteoclast and thus prevent and treating osteoporosis radically.
Application Number
申请号
02154159 Application Date
申请日
2002.12.27
Title 名称 Medicine for preventing and curing osteoporosis and its preparing method
Publication Number
公开号
1425425 Publication Date
公开日
2003.06.25
Approval Pub. Date 2007.08.08 Granted Pub. Date 2007.08.08
International Classification 分类号 A61K36/64;A61K36/487;A61K36/296;A61K36/258;A61K36/11;A61P19/10
Applicant(s) Name
申请人
Yao Zhiping
Address 地址
Inventor(s) Name 发明人 Yao Zhiping
Attorney & Agent 代理人 he jingru

  
Medicine for curing cold and influenza and complication and its preparing process
Method for preparing cow-bezoar snake bile Sichuan fritillary bulb dispersive tablet
Process for preparing Liuwei aucklandia root tablet
Blood sugar reducing tablet
Traditional Chinese medicine active part composition for curing cardio and cerebral vascular disease and its preparing method
Bone marrow recovery medicine
Urinary protein recovery pill
Shoe pad for curing foot sweat, foot odor and beriberi
Naolejing granular preparation
Medicine for curing diseases after setting contraceptive ring
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.